Find your path to Alan
Sign up to see every warm intro you have to Alan
- Paths you didn't know you had: your email and LinkedIn already hold routes to Alan. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
About
Partner at Seroba since 2003 with a background in product and business development in pharma and biotech. Previously worked at Elan Corporation, American Biogenetic Sciences and the MHRA, with earlier VC experience at Estée Lauder Investments.
Contact· self-published, not guessed
Investments
Investor
Artica TherapeuticsFusion PharmaceuticalsHeart MetabolicsPrexton TherapeuticsShorla Pharma
Per curated public sources.
Colleagues at Seroba Life Sciences
Network5
Investors connected to Alan in public investor directories — a warm-intro map.
Frequently asked questions
- Who is Alan O'Connell?
- Partner at Seroba since 2003 with a background in product and business development in pharma and biotech. Previously worked at Elan Corporation, American Biogenetic Sciences and the MHRA, with earlier VC experience at Estée Lauder Investments.
- Where does Alan O'Connell work?
- Alan O'Connell is Partner at Seroba Life Sciences.
- What check size does Alan O'Connell write?
- Alan O'Connell typically writes checks of $5M – $7M.
- What companies has Alan O'Connell invested in?
- Investments tracked here include Artica Therapeutics, Fusion Pharmaceuticals, Heart Metabolics, Prexton Therapeutics, Shorla Pharma.
About this profile. Compiled from public sources — Seroba Life Sciences's own website and public professional profiles — and summarised by Fundraising Fox; every fact is kept with where it came from. Spotted an error, or would rather not be listed? Email privacy@fundraisingfox.com · How we build profiles · Your rights







